Abcam Plc Asset Turnover Ratio (ABCM), as of fourth quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Abcam Plc  (NASDAQ: ABCM)
 

Abcam Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Abcam Plc asset turnover ratio, the ability of Abcam Plc's assets to generate revenue in the fourth quarter 2022, increased sequentially to 0.37 in the fourth quarter (Dec 31 2022), ABCM's balance sheet remain strong.

Within sector 26 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2022 compared to the preceding quarter from 0 to 2993.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABCM Asset Turnover Ratio (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Asset Change 34.94 % 12.61 % 26.68 % - -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.37 - - - -
ABCM's Total Ranking # 2993 # 0 # 0 # 0 #
Seq. Asset Change 54 % 0 % 0 % -12.37 % 28.51 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 27
Healthcare Sector # 402
Overall Market # 2993

Asset Turnover Ratio Statistics
High Average Low
0.34 0.34 0.34
(Dec 31 2022)  




ABCM Company Profile • Back to ABCM Efficiency Comparisons • Compare ABCM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2022 Assets at quarter ending Dec 31 2022
Cardiovascular Systems Inc   0.76 $ 239.843  Millions$ 317.553  Millions
Luna Innovations Inc  0.75 $ 109.497  Millions$ 145.701  Millions
Silk Road Medical Inc   0.75 $ 138.638  Millions$ 184.488  Millions
Quest Diagnostics Inc  0.75 $ 9,883.000  Millions$ 13,203.500  Millions
Harvard Bioscience Inc   0.75 $ 113.335  Millions$ 151.423  Millions
Camp4 Therapeutics Corporation  0.75 $ 284.820  Millions$ 381.580  Millions
Vivos Therapeutics Inc   0.74 $ 16.024  Millions$ 21.513  Millions
3m Company  0.74 $ 34,229.000  Millions$ 46,030.000  Millions
Greenbrook Tms Inc   0.74 $ 69.104  Millions$ 93.120  Millions
Evolus Inc   0.74 $ 148.616  Millions$ 200.571  Millions
Staar Surgical Co  0.74 $ 284.391  Millions$ 384.194  Millions
Nabriva Therapeutics Plc  0.74 $ 36.935  Millions$ 50.170  Millions
Elite Pharmaceuticals Inc   0.73 $ 30.947  Millions$ 42.187  Millions
Biontech Se  0.73 $ 18,235.540  Millions$ 24,903.981  Millions
Ethema Health Corporation   0.73 $ 4.821  Millions$ 6.595  Millions
Masimo Corp  0.73 $ 2,034.900  Millions$ 2,784.224  Millions
Carlisle Companies Incorporated  0.73 $ 5,449.400  Millions$ 7,463.675  Millions
Moderna Inc   0.73 $ 19,263.000  Millions$ 26,391.500  Millions
Bruker Corporation  0.73 $ 2,530.700  Millions$ 3,471.050  Millions
Vystar Corporation  0.73 $ 10.518  Millions$ 14.495  Millions
U s Stem Cell Inc   0.72 $ 0.082  Millions$ 0.113  Millions
Venus Concept Inc   0.72 $ 94.507  Millions$ 130.794  Millions
Novo Nordisk A  0.72 $ 25,053.803  Millions$ 34,706.245  Millions
Sonoma Pharmaceuticals Inc   0.72 $ 12.556  Millions$ 17.453  Millions
Dynavax Technologies Corporation  0.72 $ 721.683  Millions$ 1,004.290  Millions
Nevro Corp   0.72 $ 406.365  Millions$ 566.179  Millions
Enzo Biochem Inc  0.72 $ 61.123  Millions$ 85.292  Millions
Avricore Health Inc   0.72 $ 1.360  Millions$ 1.898  Millions
Tenet Healthcare Corp  0.71 $ 19,174.000  Millions$ 26,875.750  Millions
Smiledirectclub Inc   0.71 $ 470.743  Millions$ 659.917  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.